Skip to main content
SpringerLink
Log in

CVD medication costs impart burden on healthcare system

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2014 US dollars

  2. Framingham Risk Score

References

  1. Shaw LJ, et al. 10-Year Resource Utilization and Costs for Cardiovascular Care. Journal of the American College of Cardiology 71: 1078-1089, No. 10, 13 Mar 2018. Available from: URL: http://doi.org/10.1016/j.jacc.2017.12.064.

    Article  PubMed  Google Scholar 

  2. Kazi DS. Building the Economic Case for Investment in Cardiovascular Prevention. Journal of the American College of Cardiology 71: 1090-1093, No. 10, 13 Mar 2018. Available from: URL: http://doi.org/10.1016/j.jacc.2018.01.022.

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

CVD medication costs impart burden on healthcare system. PharmacoEcon Outcomes News 799, 14 (2018). https://doi.org/10.1007/s40274-018-4796-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4796-3

Search

Navigation